evaluable

adj.

可估值的，可评价的；

Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated mal...
Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ra...
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus...
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of...
High-dose dexamethasone for refractory or relapsing multiple myeloma
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem...
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free int...
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.